HEALTH● LOW1h ago · Sep 14, 2026, 12:34 AM
FDA approves Telix brain cancer imaging drug Pixclara
Seeking Alpha Tech · north america
The FDA has approved Pixclara, an imaging drug developed by Telix for brain cancer. This approval indicates a new tool available for diagnosing or monitoring brain cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoMan up, break down: unpacking the Philippines’ male suicide crisisSouth China Morning PostHEALTH2h agoWeight-loss drug may also slow ageing – StudyVanguard NigeriaHEALTH2h agoPennsylvania says an unvaccinated woman has died from measles-related complicationsNPR NewsHEALTH2h agoOne more epidemic we are not paying attention toClarín